Stage 4 stomach cancer is diagnosed in approximately 30,300 Americans annually, which is 1.5% of all cancers [6]. The highest risk is for people over 55. This type of oncology presents serious challenges, but newer treatments in advanced medical centers improve outcomes. Modern therapies – like HIPEC, PIPAC, and dendritic cell vaccines – are really valuable at this stage of oncology, allowing patients to maintain their quality of life in addition to disease control. Start the specialized treatment ASAP, your diagnosis mustn’t be the main thing that defines your future.
What is Stage 4 Stomach Cancer
Stage 4 stomach cancer means the cancer has spread from your stomach to other parts of your body. Liver, lungs, or the lining of abdomen are the most common locations [7]. Doctors call such cancer metastatic.
Metastatic cancer cannot typically be cured due to its significant spread, but this doesn't mean there's nothing that can be done. Treatments must be started that focus on cancer's growth control and managing symptoms. This helps you maintain the best possible quality of life (QoL). So, QoL becomes the primary goal.
The survival statistics you might read – showing a 7% five-year survival rate – represent averages from large groups of people. These numbers cannot predict what will happen in your specific situation, as many factors influence how you might respond to therapy:
- Your age and other medical conditions
- The specific characteristics of your cancer cells
- Whether doctors can remove some of the cancer with surgery
In addition, these statistics often reflect older treatments. It may not account for newer therapies available.
Yes, each individual can respond to treatment differently, and it can be difficult to evaluate all the factors that influence the course of the disease. That is why a team of medical specialists at Booking Health will carefully evaluate your documentation, arrange all the needed tests to determine your tumor’s specific characteristics, and overall health to perfectly match your diagnosis with the treatment plan and clinic.
We are providing an initial consultation within 24 hours after you submit your documents and identify the most effective, evidence-based strategy tailored to your specific case, especially when standard options have been exhausted.
Stage 4 Stomach Cancer Treatment – Standard Options
At stage 4 stomach cancer, standard treatment focuses on controlling the disease, symptoms management, and quality of life – rather than achieving a cure.
Chemotherapy remains the first-line treatment in many countries. Different drug combinations can slow down the growth of the tumor. The appropriate regimens are selected based on the patients' overall health and their ability to tolerate the treatment. Chemotherapy can extend the survival and provide symptom control, but the response of the tumor is often unpredictable, and cancer can become resistant over time.
Radiation therapy uses high-energy beams to manage symptoms. It helps with bleeding control and reduces pain. The tumor can also be shrunk with the help of radiation, which will result is redused stomach blockage. However, radiation therapy alone is rarely a curative late-stage stomach cancer treatment.
Surgery has a more limited role. Surgery for stage 4 gastric cancer may be recommended for:
- Removing tumors causing severe bleeding
- Bypassing the obstructed areas to restore normal eating
- Symptoms relief
Standard procedures can give patients significant benefits, but do not much improve survival, and modern medicine strives for more. The need for innovation is indicated by the quick progression of disease after the use of conventional treatments.
Innovative Therapies for Late-Stage Stomach Cancer
Standard protocols are a valuable basis, but modern medicine has therapies that go far beyond standard chemo and radiation for late-stage stomach cancer. These treatments can reach cancer cells, that conventional therapies often miss. Another advantage is spared QoL.
Fighting Stomach Cancer with Controlled Heat: Hyperthermia
This stage 4 stomach cancer treatment uses controlled heat to elevate the temperature in targeted areas to 104-113°F. This helps by boosting the standard treatments like chemotherapy. Cancer cells are more vulnerable to high temperatures, and healthy cells are not.
The mechanism involves a disruption in the cell repair enzyme system that helps malignant cells recover from chemotherapy and radiation, thereby blocking their regeneration. When the temperature reaches above 104°F, the activated heat shock proteins signal to the immune system about cancer cells and make their recognition much easier. When the temperature is 107°F, the programmed cell death is activated in the cancer tissue.
The local hyperthermia is used for precise tumor targeting, regional hyperthermia works for larger areas, and whole-body hyperthermia is applied when there is metastatic spread.
Key advantages for stage 4 stomach cancer treatment include:
- Enhanced effectiveness of chemotherapy and radiation by 30-50%
- Renewed sensitivity in previously resistant tumors
- Improved blood flow for better drug delivery
- Minimal damage to surrounding healthy tissue
- Compatible with other cancer treatments
It is an accessible option for patients who want to maximize their treatment effectiveness. Hyperthermia sessions are scheduled over several weeks, it doesn’t require lengthy hospital stay.
HIPEC: Heated Chemotherapy for Deep Abdominal Cancer
When stomach cancer spreads to abdominal lining, HIPEC is used. Traditional surgery often cannot remove malignant tissue completely. HIPEC combines tumor removal with direct delivery of heated chemotherapy to the abdomen – and this is a valuable benefit.
This specialized procedure involves two critical steps. First, cytoreductive surgery comes, i.e. surgeons remove all visible tumors in the abdominal cavity and affected organs. Second, a heated solution of chemo medications circulates directly throughout the abdomen for 90 minutes. This stage kills microscopic cancer cells that surgery cannot reach.
The heated chemotherapy is administered in concentrations 15-20 times higher than the usual intravenous injections, but with less exposure to the rest of your body. Heat increases drug penetration and effectiveness, impairing cancer cells’ ability to repair themselves and helping destroy them.
During treatment of adenocarcinoma of stomach stage 4, HIPEC offers several advantages:
- Targets cancer cells that conventional approaches often miss
- Delivers extremely high drug concentrations directly to affected areas
- Heat makes cancer cells more vulnerable to chemotherapy
- Can achieve disease control when other methods have failed
- Potentially curative for select patients with limited spread
HIPEC is a complex procedure and requires an experienced medical team and modern equipment that is available at selected cancer treatment facilities in Germany. Booking Health has over 20 years of experience and ISO 9001 quality certificates and works hard to connect patients with the best treatment facilities to ensure an excellent level of care.
We work directly with the hospital and offer rapid access so that those with advanced stomach cancer can start treatment as soon as possible.
Get full treatment coordination supportLeading German surgeon Dr. Michael Lipp, who has performed HIPEC procedures since 2015, explains why this intervention represents the only potentially curative option for abdominal spread and how proper patient selection can lead to complete cancer cure in select cases.
VIDEO
Leading German Surgeon
Dr. Lipp Reveals the Power of HIPEC in Cancer Treatment
General and Abdominal Surgery, Hepatopancreatobiliary Surgery and Hernia Surgery
BOOK CONSULTATION
PIPAC: Aerosol Chemotherapy for Hard-to-Reach Cancer Sites
PIPAC is a "lighter" alternative to HIPEC that can be used in patients with stomach cancer that has spread to the abdominal lining. HIPEC requires major surgery lasting many hours. PIPAC is a minimally invasive procedure – suitable for patients who are not able to tolerate extensive operations.
The technique uses laparoscopic surgery, requiring only two small abdominal incisions. Chemotherapy is transformed into a pressurized aerosol and distributed throughout the abdominal cavity under controlled pressure. The aerosol penetrates tumor tissues better than conventional liquid chemotherapy, reaching areas that other treatments often miss.
The procedure typically lasts only 60-90 minutes and can be repeated multiple times as needed. Unlike HIPEC's single procedure approach, PIPAC allows for ongoing stage 4 adenocarcinoma of stomach treatment through repeated sessions, making it valuable for patients requiring long-term care.
Key advantages include:
- Minimal physical trauma with faster recovery
- Outpatient procedures or short hospital stays of 2-3 days
- Can be safely repeated as disease management requires
- Compatible with ongoing systemic chemotherapy
- Suitable option for patients too frail for major surgery
- May potentially downstage the disease for future surgical options
Recent studies show, that patients receiving three or more PIPAC treatments achieve better survival outcomes and stronger clinical responses while maintaining shorter hospital stays, making this an accessible option for late-stage stomach cancer treatment.
TACE: Targeted Treatment Through Blood Vessel Blocking
Transarterial chemoembolization is a valuable technique for the destruction of stomach cancer metastases, particularly in the liver – spread here often becomes life-threatening. TACE is a minimally invasive procedure that targets multiple metastases simultaneously within one anatomical region. It delivers concentrated chemotherapy directly where it's needed.
TACE is carried out as follows. An interventional radiologist inserts a thin catheter through a small groin incision and navigates it through blood vessels to reach the arteries feeding the tumor or metastases. Advanced imaging guidance helps do this. After that, concentrated chemo drugs are injected into vessels – followed by embolic materials to block blood flow.
This dual-action approach works by starving tumors of their blood supply and delivering drug concentrations up to 20 times higher than traditional IV chemotherapy can.
Key advantages include:
- Targets multiple metastases in one session
- Delivers extremely high drug concentrations directly to tumors
- Minimal systemic side effects compared to conventional chemotherapy
- Can be repeated as needed for ongoing disease control
- Often performed as an outpatient procedure with a short recovery
VIDEO
Prof. Kovács: When to Use DEB-TACE, Conventional TACE, or Radioembolization (TARE)
Interventional Radiology
BOOK CONSULTATION
For patients who are battling advanced metastatic disease, the question is no longer only which treatment works, but which can be effective enough and not worsen the patient’s overall health. Minimally invasive procedures like TACE can be an optimal solution to achieve desired results and still maintain their quality of life.
Booking Health medical specialists review your specific case and match the patient’s current functional status and prior treatment history to centers with documented experience in minimally invasive localized chemotherapy.
CHECK IF A BETTER SOLUTION EXISTS FOR YOURegional Chemotherapy: Delivers Chemo Where It Is Necessary
For metastatic adenocarcinoma of stomach, regional chemotherapy solves a fundamental problem: conventional treatment dilutes across your entire bloodstream before reaching tumors. Direct arterial delivery changes everything – flooding cancerous tissue with concentrations 15-20 times higher than systemic methods achieve.
During the procedure interventional radiologists thread thin catheters through a small groin incision, navigating toward tumor-feeding arteries under imaging guidance. Three techniques target different patterns. Hypoxic abdominal stop-flow perfusion temporarily halts circulation to trap drugs where peritoneal metastases concentrate; upper abdominal perfusion isolates the gastric region; intraarterial infusion continuously feeds chemotherapy through tumor vessels. Blood filtration removes residual drugs within 45 minutes.
Among the key advantages are minimal systemic toxicity. And as for clinical outcomes, patients with peritoneal metastases who had exhausted all standard options achieved 17.4-month median survival – extending to 23.5 months for those with prior resection [8].
Electrochemotherapy for Stomach Cancer Stage 4
Electrochemotherapy treatment for metastatic stomach cancer uses controlled electrical currents to perforate tumor cell membranes – creating temporary nanoscale openings that allow chemotherapy to flood inside at high concentrations. Brief pulses open cellular doorways where none existed and the chemo follows: drugs penetrate 70-80% more effectively.
Under general anesthesia, surgeons position specialized needle electrodes around tumors at precise 2.5-3 cm intervals using imaging guidance. Computer-controlled generators deliver pulses synchronized with cardiac rhythm – preventing arrhythmia while creating membrane pores. Chemo agents immediately surge through these openings. Most patients leave the healthcare facility within 24-48 hours.
The method targets tumors near vital organs where surgery risks too much. It is effective against peritoneal metastases resistant to systemic treatment. The cost of electrochemotherapy ranges from €7,500-12,000 – electrochemotherapy cost is considerably less than repeated conventional cycles while delivering superior precision. Electro-chemotherapy is particularly valuable for advanced disease.
Targeted Therapy: Treatments Tailored to Your Cancer
This is a precision medicine approach. It adjusts a therapeutic protocol to a patient’s tumor's unique genetic features. Targeted treatments specifically attack cancer cells based on their molecular characteristics – unlike traditional chemotherapy, which affects all rapidly dividing cells.
Several groups of targeted medications show promise for stomach cancer. These are HER2-targeting antibodies (bind to cancer cells overproducing the HER2 protein and block growth signals), anti-angiogenesis drugs (block tumor blood vessel formation and cut off nutrients), growth factor inhibitors (interfere with cellular communication pathways that stimulate cancer proliferation), protein-targeting antibodies (attack specific proteins on stomach cancer cells). And more to be discovered.
Key advantages of targeted therapy include:
- Personalized approach – based on your tumor's genetic profile
- Can work when traditional chemo proves insufficient
- Potential for combination with other treatments and creating personalized schemes
- Often fewer side effects than traditional chemo
These precision therapies are becoming increasingly important tools in the fight against terminal stomach cancer.
Dendritic Cell Therapy – Your Immune System Fights
Dendritic cell therapy trains specialized immune cells called dendritic cells to recognize and destroy cancer. These cells, often called the "officers" of immunity, naturally present threats to other immune cells but often fail to function properly in cancer patients. The Nobel Committee acknowledged the role of dendritic cells by awarding the 2011 Nobel Prize in Medicine to their discoverer, American immunologist Ralph Steinman.
This treatment for adenocarcinoma stomach cancer stage 4 in Germany involves collecting a blood sample from which dendritic cells are extracted and cultured in a laboratory for one week. Cells are "educated" to recognize specific proteins on cancer cells – so a personalized vaccine is created. When reinfused, these trained dendritic cells activate your immune system's T-cells and boost a targeted anti-cancer response.
Key advantages include:
- Minimal side effects – primarily mild flu-like symptoms for 1-2 days
- Creates lasting immunity that continues working after treatment ends
- Compatible with other cancer treatments like chemotherapy and surgical interventions
- Suitable even for patients too frail for aggressive conventional treatments
- Personalized approach using your own immune cells and tumor antigens
Prof. Frank Gansauge is one of Germany's most experienced dendritic cell specialists with over 22 years of experience. He explains how this innovative immunotherapy for stomach cancer can significantly extend survival and potentially achieve complete responses in advanced gastric cancer patients.
VIDEO
Prof. Frank Gansauge: How Dendritic Cell Therapy is Transforming Modern Cancer Treatment
Dendritic Cell Therapy
BOOK CONSULTATION
Traditional vs. Innovative Approaches for Advanced Gastric Cancer
Source: Booking Health clinical analytics. Actual treatment expenses vary based on individual patient requirements, hospitalization duration, continuous medical oversight demands, and supplementary costs including diagnostic procedures, travel arrangements, and accommodation services.
| Characteristic | Standard Methods | Innovative Methods |
|---|---|---|
| 2-Year Survival Rate | Approximately 25% for metastatic cancer | Up to 60% for metastatic disease |
| Response Rate | Less than 10% positive outcomes | 45-65% positive response |
| Time Investment | Multiple rounds spanning months | Up to 4 sessions |
| Side Effects | Extensive systemic impact (nausea, severe fatigue, total hair loss, weakened immunity, skin reactions) | Predominantly minor effects (primarily localized temporary discomfort) |
| Cost of Treatment in Germany | €80,000 - €150,000 full course | €25,000 - €60,000 full course |
| Cost of Treatment in Great Britain | €90,000 - €165,000 full course | €70,000 - €120,000 full course |
| Cost of Treatment in the USA | €100,000 - €180,000 full course | €100,000 - €150,000 full course |
Real Patient Stories and Treatment Outcomes
Majid Naji Al Obaidi from Iraq decided to seek advanced treatment abroad when he received a diagnosis of metastatic stomach cancer. After the investigation, he chose the University Hospital Frankfurt am Main and Prof. Vogl for TACE.
"We booked at Booking Health for stomach cancer treatment," Majid shares. "The medical advisor contacted us and explained the treatment program, provided all necessary medical info. Miss Nour, the travel manager, was in constant contact to help facilitate visa procedures from Iraq, transportation, coordinate hospital appointments, and answer all inquiries."
His treatment was carried out in two stages. First, he received comprehensive care at the Clinic of Advanced Biological Medicine with Dr. Siebenhühner, which included specialized infusion therapy and additional supportive treatments. Following this phase, he underwent TACE at the University Hospital Frankfurt with Prof. Vogl.
"Praise be to God, the whole team was cooperating with us. We would like to thank them very much. I recommend this company to anyone looking for treatment in Germany."
Majid's experience demonstrates how advanced treatments like TACE can be integrated into comprehensive care programs, providing patients with metastatic disease access to cutting-edge therapeutic options that may not be available in their home countries.
Regain Hope with Innovative Stage 4 Stomach Cancer Treatments
Stage 4 stomach cancer: these words reshape everything you thought you knew about tomorrow. What comes next? The question echoes while hope seems to fade.
Medical science hasn't stood still. Breakthrough therapies change outcomes for patients with advanced disease, offering possibilities that didn't exist even 5 years ago. These aren't improvements – they represent fundamentally different approaches to fighting cancer.
Traditional treatments often demand weeks in hospital, accompanied by side effects that steal your quality of life. Many innovative therapies work differently: completion in days rather than months, minimal disruption, preserved dignity. Can you maintain normalcy while fighting advanced disease? The answer is yes.
Leading international medical centers offer advantages. State-of-the-art equipment gives precision. Oncology specialists bring extensive training in cutting-edge methods. Facilities provide comprehensive care that goes beyond treatment alone – they understand what you're experiencing. These centers offer access to progressive options that achieve long-term disease control, outcomes that may remain unavailable closer to home.
How do advanced therapies differ from conventional approaches? Talking about HIPEC, PIPAC, TACE, hyperthermia, and dendritic cell immunotherapy – each targets cancer cells in its own way and spares healthy tissue. Fewer side effects mean preserved quality of life. You can continue being yourself.
Consider what's now achievable:
- Disease progression halted, tumor growth controlled
- Survival extended well beyond traditional expectations
- Immune function strengthened, overall health improved
- Dignity and comfort maintained
- Hope restored when conventional medicine offers little
Will these treatments cure stage 4 cancer? Often, no. But they represent powerful tools for extending meaningful life – time with those you love, experiences that matter, moments worth fighting for. Centers worldwide are achieving results that seemed impossible a decade ago.
A Medical Journey: Every Step of the Way With Booking Health
Finding the best treatment strategy for your clinical situation is a challenging task. Being already exhausted from multiple treatment sessions, having consulted numerous specialists, and having tried various therapeutic interventions, you may be lost in all the information given by the doctors. In such a situation, it is easy to choose a first-hand option or to follow standardized therapeutic protocols with a long list of adverse effects instead of selecting highly specialized innovative treatment options.
To make an informed choice and get a personalized cancer management plan, which will be tailored to your specific clinical situation, consult medical experts at Booking Health. Being at the forefront of offering the latest medical innovations for already 12 years, Booking Health possesses solid expertise in creating complex cancer management programs in each case. As a reputable company, Booking Health offers personalized stage 4 stomach cancer treatment plans with direct clinic booking and full support at every stage, from organizational processes to assistance during treatment.
We provide:
- Assessment and analysis of medical reports
- Development of the medical care program
- Selection of a suitable treatment location
- Preparation of medical documents and forwarding to a suitable clinic
- Preparatory consultations with clinicians for the development of medical care programs
- Expert advice during the hospital stay
- Follow-up care after the patient returns to their native country after completing the medical care program
- Taking care of formalities as part of the preparation for the medical care program
- Coordination and organization of the patient's stay in a foreign country
- Assistance with visas and tickets
- A personal coordinator and interpreter with 24/7 support
- Transparent budgeting with no hidden costs
Health is an invaluable aspect of our lives. Delegating management of something so fragile yet precious should be done only to experts with proven experience and a reputation. Booking Health is a trustworthy partner who assists you on the way of pursuing stronger health and a better quality of life. Contact our medical consultant to learn more about the possibilities of personalized treatment with innovative methods for metastatic stomach cancer with leading specialists in this field.
Booking Health holds ISO 9001 quality certification, reflecting well-established processes and strict quality control at every stage of the treatment journey — not just at the initial consultation, but throughout.
Modern Cancer Treatment: Patient Journeys with Booking Health
Frequently Asked Questions of Our Patients About Stage 4 Stomach Cancer Treatment
Metastatic adenocarcinoma of stomach is stage 4 cancer where adenocarcinoma has spread to distant organs. This is the most common histological type of stomach cancer.
In advanced stages adenocarcinoma of the stomach can be highly aggressive. Traditional treatments show a 7% five-year survival rate for stage 4, though innovative therapies – HIPEC, PIPAC, and dendritic cell immunotherapy – achieve up to 60% two-year survival rates for metastatic disease.
Stage 4 stomach cancer cannot typically be cured with surgery alone. But treatments like HIPEC can be potentially curative for selected patients, patients with limited spread.
Traditional statistics show a 7% five-year survival rate, but innovative cancer treatment methods achieve up to 60% two-year survival rates for metastatic disease. Individual outcomes vary based on cancer characteristics and treatment response.
The most effective approaches are innovative therapies that target cancer cells more precisely than conventional stomach cancer treatments. These are HIPEC, PIPAC, TACE, and dendritic cell immunotherapy.
Surgery plays a limited but valuable role – primarily to manage bleeding, bypass obstructions, or can be part of HIPEC procedures. HIPEC, i.e., cytoreductive surgery combined with heated chemotherapy, offers the best outcomes.
Yes, it is dendritic cell therapy that trains your immune system to recognize and destroy cancer cells. This personalized immunotherapy creates lasting immunity. It has minimal side effects and numerous benefits, including compatibility with other treatments.
Treatment price varies by location and method. Innovative therapies range from €25,000-€60,000 in Germany. Traditional approaches cost between €80,000-€150,000. Expenses depend on individual factors, hospitalization duration..
Yes. Leading international hospitals provide comprehensive access to anti-cancer therapies and oncology experts. Booking Health facilitates treatment abroad. The Booking Health team offers personalized programs – with full support from clinic selection to treatment coordination.
Stage 4 stomach cancer often causes persistent stomach pain, loss of appetite, nausea, vomiting, unintentional weight loss, fatigue, and abdominal swelling. When metastases are present, symptoms may also include jaundice, shortness of breath, or bone pain.
For stage 4 stomach cancer, the 2-year survival rate with standard treatments averages around 25%. On the other hand, innovative therapies (e.g., HIPEC, PIPAC, TACE, or dendritic cell therapy) can increase it to up to 60% according to clinical data.
The response rate for conventional therapies in stage 4 stomach cancer is typically below 10%. In comparison, advanced methods (HIPEC or dendritic cell immunotherapy) show 45-65% positive response rates.
Traditional treatments for stage 4 stomach cancer often cause severe side effects, including nausea, fatigue, and immune suppression. In contrast, innovative therapies (e.g., PIPAC, HIPEC, and dendritic cell immunotherapy) generally cause milder effects, mostly limited to short-term local discomfort.
Stage 4 stomach cancer requires treatment, that can act locally and systemically at the same time. In Germany this is achieved through approaches such as HIPEC and PIPAC (for peritoneal carcinomatosis), TACE (for liver involvement), dendritic cell therapy and targeted drugs which expand options beyond conventional chemotherapy.
The best hospitals for stage 4 stomach cancer are those capable of performing complex procedures rather than only systemic therapy. In Germany specialized centers combine HIPEC, PIPAC, interventional radiology and immune-based treatments within coordinated treatment pathways for advanced gastric cancer.
When standard protocols are no longer sufficient Germany offers broader treatment possibilities for stage 4 stomach cancer. The availability of innovative methods allows patients to receive treatment strategies, that are rarely combined in routine oncology care elsewhere.
Choose treatment abroad and you will for sure get the best results!
Sources:
01. Luigi Marano, Daniele Marrelli, Paolo Sammartino et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'. Ann Surg Oncol. 2021 Dec;28(13):9060-9070. doi: 10.1245/s10434-021-10157-0. Epub 2021 May 31. [DOI] [PubMed]
02. Matthew Krell, Suedeh Ranjbar, Saige Gitlin et al. Evolution in the Surgical Management of Gastric Cancer Peritoneal Metastases. Cancers (Basel). 2024 Dec 31;17(1):100. doi: 10.3390/cancers17010100. [DOI] [PubMed]
03. Fiorentini G et al Anticancer Res 2012;32:1387. Aliberti C et al Ancancer Res 2011;31:4581. Richardson A et al J Vasc Interv Radiol 2013;24:1209
04. Bohui Zhu, Yiyuan Sun, Xiaoqing Wei et al. Dendritic Cell Vaccine Loaded with MG-7 Antigen Induces Cytotoxic T Lymphocyte Responses against Gastric Cancer. J Healthc Eng. 2022 Apr 18:2022:1964081. doi: 10.1155/2022/1964081. eCollection 2022. [DOI] [PubMed]
05. Roman Volchenkov, Florian Sprater, Petra Vogelsang, Silke Appel. The 2011 Nobel Prize in physiology or medicine. Scand J Immunol. 2012 Jan;75(1):1-4. doi: 10.1111/j.1365-3083.2011.02663.x. [DOI] [PubMed]
06. American Cancer Society. Key Statistics About Stomach Cancer.
07. Cancer Research UK. Stage 4 stomach cancer.
08. Aigner K, Vashist YK, Selak E, Gailhofer S, Aigner KR. Efficacy of Regional Chemotherapy Approach in Peritoneal Metastatic Gastric Cancer. J Clin Med. 2021;10(23):5322. https://doi.org/10.3390/jcm10225322 [DOI]
Read:
01. New Effective Treatments for Stage 4 Cancer: Innovations in Oncology
